Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. Innovation is increasingly intertwined with advancements in ...

Whether driven by institutional goals or personal career ambitions, researchers are increasingly under pressure to deliver high-performing, high-impact research. The challenge is to secure funding, ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral ...

Chris Boshoff to lead all Research and Development functions including Oncology Oncology Unit end-to-end structure to remain intact, reporting to Boshoff Roger Dansey to become Interim Chief Oncology ...

With the advent of generative AI (genAI), the potential scope of artificial intelligence has increased dramatically, but the future effect of genAI on productivity remains uncertain. The effect of the ...

Ryan Summers receives funding from the National Science Foundation (NSF) and the National Institutes of Health (NIH). He is affiliated with the Association for Science Teacher Education (ASTE), NARST, ...

This year, the Department of Defense was authorized to spend $34 billion more on research and development than it was two years ago and only $18 billion more on procurement of new aircraft and ships.

WASHINGTON (AP) — The Environmental Protection Agency said Friday it is eliminating its research and development arm and reducing agency staff by thousands of employees. The agency’s Office of ...

Massachusetts-based Insilico's proprietary generative AI platform, Pharma.AI, utilizes biology, clinical medicine, scientific research and generative chemistry for drug discovery. The company says ...